Next Article in Journal
Therapy-Induced Senescence: An “Old” Friend Becomes the Enemy
Next Article in Special Issue
[18F]FET-βAG-TOCA: The Design, Evaluation and Clinical Translation of a Fluorinated Octreotide
Previous Article in Journal
Frequent FOXA1-Activating Mutations in Extramammary Paget’s Disease
Previous Article in Special Issue
Affibody Molecules as Targeting Vectors for PET Imaging
Open AccessReview

Metastatic Heterogeneity of Breast Cancer: Companion and Theranostic Approach in Nuclear Medicine

1
Département de Biologie Médicale, Centre Scientifique de Monaco, 98000 Monaco, Monaco
2
Institute for Research on Cancer and Aging of Nice, Centre Antoine Lacassagne, CNRS UMR 7284 and INSERM U1081, University Côte d’Azur, 06200 Nice, France
*
Author to whom correspondence should be addressed.
Cancers 2020, 12(4), 821; https://doi.org/10.3390/cancers12040821
Received: 21 February 2020 / Revised: 3 March 2020 / Accepted: 5 March 2020 / Published: 29 March 2020
(This article belongs to the Special Issue Cancer Molecular Imaging)
Breast cancer is the most common malignancy in women throughout the world. Metastatic dissemination to vital organs is the leading cause of breast cancer-related deaths. The treatment of metastases is mainly based on the primary tumor characteristics. However, breast cancer metastases exhibit high heterogeneity leading to different prognosis and therapeutic responses. Getting access to phenotype of metastases would allow better management of patients. The advent of theranostics in nuclear medicine has opened new opportunities for the diagnosis and treatment of cancer patients. The aim of this review is to provide an overview of current knowledge and future directions in nuclear medicine for therapeutic management of metastatic breast cancer patients. View Full-Text
Keywords: breast cancer; metastasis; nuclear medicine; theranostics breast cancer; metastasis; nuclear medicine; theranostics
Show Figures

Figure 1

MDPI and ACS Style

Montemagno, C.; Pagès, G. Metastatic Heterogeneity of Breast Cancer: Companion and Theranostic Approach in Nuclear Medicine. Cancers 2020, 12, 821.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop